Marlatt, Kara L.
Greenway, Frank L. http://orcid.org/0000-0002-1766-6111
Kyle Schwab, J.
Ravussin, Eric
Article History
Received: 14 February 2019
Revised: 5 June 2019
Accepted: 17 June 2019
First Online: 19 July 2019
Compliance with ethical standards
:
: ER is the inventor of the used technology and is seeking patent protection. FLG has a patent application that is pending for an insulin sensitizer. The remaining authors declare that they have no conflict of interest.